The Africa Gazette
SEE OTHER BRANDS

The latest news from Africa

The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

Press releases published on April 1, 2025

Atticus Publishing proudly presents 'You Deserve Life' by Dr. Karen Wright-Chisolm

Atticus Publishing proudly presents 'You Deserve Life' by Dr. Karen Wright-Chisolm

Unveils Triumph Over Domestic Violence Through Faith CHARLESTON, SC, UNITED STATES, April 1, 2025 /⁨EINPresswire.com⁩/ -- In her profound book, You Deserve Life, Dr. Karen Wright-Chisolm shares her personal journey and stories of those who faced domestic …

VRIZE Recognized Among the Fastest-Growing Companies in the Inc. Southeast Regionals

VRIZE Recognized Among the Fastest-Growing Companies in the Inc. Southeast Regionals

VRIZE Secures a Spot in the Southeast’s Top 192, Contributing to 11,493 Jobs and an $8.1B Economic Impact TAMPA, FL, UNITED STATES, April 1, 2025 /⁨EINPresswire.com⁩/ -- Inc. magazine today announced that VRIZE has been ranked No. 43 on its fifth annual …

Brigitte Poublon Gives Update on former Teen Idol, Bobby Sherman: Bobby is Terminal Ill, Resting Comfortably

Brigitte Poublon Gives Update on former Teen Idol, Bobby Sherman: Bobby is Terminal Ill, Resting Comfortably

On Tuesday, Bobby Sherman’s wife, Brigitte Poublon gave an update on Bobby Sherman’s health: “Bobby Sherman is terminally ill and resting comfortably.” LOS ANGELES, CA, UNITED STATES, April 1, 2025 /⁨EINPresswire.com⁩/ -- On Tuesday, Bobby Sherman’s wife, …

Quorum Software Launches Global Partner Advantage Program

Quorum Software Launches Global Partner Advantage Program

Empowering Collaboration and Accelerating Partner Success HOUSTON, TX, UNITED STATES, April 1, 2025 /⁨EINPresswire.com⁩/ -- Quorum Software, a global leader in energy software, today announced the launch of the Quorum Partner Advantage Program, a …

C Mauritius Palmar Recertified for Ongoing Commitment to Cultivating Sustainability

C Mauritius Palmar Recertified for Ongoing Commitment to Cultivating Sustainability

Green Globe has recertified C Mauritius Palmar, a premier resort nestled along the coastline of Palmar, for its ongoing excellence in sustainability. SANTA MONICA, CA, UNITED STATES, April 1, 2025 /⁨EINPresswire.com⁩/ -- Green Globe has officially …

TCIS Africa 2025: Revolutionizing Clinical Research in Africa

TCIS Africa 2025: Revolutionizing Clinical Research in Africa

TCIS Africa is proud to announce the 6th Annual Clinical Investigators' Summit (TCIS Africa 2025), taking place on May 5-9, 2025, in Dakar, Senegal. DAKAR, SENEGAL, April 1, 2025 /⁨EINPresswire.com⁩/ -- TCIS Africa is proud to announce the 6th Annual …

COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order

COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order

TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and …

New Orleans Mayor Latoya Cantrell Champions Empowerment with a City Proclamation for His Love Is Amazing Movement

New Orleans Mayor Latoya Cantrell Champions Empowerment with a City Proclamation for His Love Is Amazing Movement

His Love is Amazing Founder Apostle Mardia Scott's Movement Operates on Three Pillars: Declaration, Motivation, and Demonstration NEW ORLEANS, LA, UNITED STATES, April 1, 2025 /⁨EINPresswire.com⁩/ -- In a powerful declaration of support for youth …

Ero Copper to Release First Quarter 2025 Operating and Financial Results on May 5, 2025

Ero Copper to Release First Quarter 2025 Operating and Financial Results on May 5, 2025

VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (the “Company”) will publish its first quarter 2025 operating and financial results on Monday, May 5, 2025, after market close. The Company will host a …

Helios Fairfax Partners to Host Investor Presentation on Wednesday, April 9, 2025, at 2:30 pm ET and Annual and Special Meeting of Shareholders on Wednesday, May 14, 2025, at 11:00 am ET

Helios Fairfax Partners to Host Investor Presentation on Wednesday, April 9, 2025, at 2:30 pm ET and Annual and Special Meeting of Shareholders on Wednesday, May 14, 2025, at 11:00 am ET

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) (“HFP”) today announced it will host an Investor Presentation on …

Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting

REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced 11 oral and poster …

Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma

Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma

MELBOURNE, Australia, April 02, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX, Telix, the Company) today announces that a first patient has been dosed in the Phase 1 ZOLAR1 trial of TLX300-CDx (89Zr-olaratumab) in patients …

Stallion Uranium Announces C$1.2 Million Private Placement

Stallion Uranium Announces C$1.2 Million Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to …

GRI Bio Announces Pricing of $5.0 Million Public Offering

GRI Bio Announces Pricing of $5.0 Million Public Offering

LA JOLLA, CA, April 01, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and …

Endeavour Silver Increases Previously Announced Bought Deal Financing to US$45 Million

Endeavour Silver Increases Previously Announced Bought Deal Financing to US$45 Million

The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within two business days, through SEDAR+ All dollar amounts are stated in United States (U.S.) Dollars unless otherwise noted. VANCOUVER, British Columbia, April 01, …

GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)

GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)

The Independent Data Monitoring Committee (IDMC) has recommended to continue study as planned as there are no safety concerns seen in the data reviewed Interim results demonstrate GRI-0621 to be safe and well-tolerated in the first 12 patients evaluated …

Holding(s) in Company

Holding(s) in Company

Reykjavík, April 01, 2025 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)   1a. Identity of the issuer or the …

Clene to Present at the Jones Healthcare and Technology Innovation Conference

Clene to Present at the Jones Healthcare and Technology Innovation Conference

SALT LAKE CITY, April 01, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the …

Cerevance Presents Topline Results from Phase 2 ASCEND Trial of Solengepras as Monotherapy Treatment for Early-Stage Parkinson’s Disease at AD/PD 2025

Cerevance Presents Topline Results from Phase 2 ASCEND Trial of Solengepras as Monotherapy Treatment for Early-Stage Parkinson’s Disease at AD/PD 2025

Solengepras showed evidence of potential benefit in functional and non-motor symptoms versus placebo as measured by MDS-UPRDS Parts I, II, NMSS, and ESS, consistent with its novel non-dopaminergic mechanism of action This investigational treatment was …

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment

The clinical trial is designed to evaluate the safety, tolerability and efficacy of Clearmind’s innovative, psychedelic-derived, MEAI-based compound in individuals with alcohol addiction Vancouver, Canada, April 01, 2025 (GLOBE NEWSWIRE) -- Clearmind …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service